• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗风险。一项关于类风湿性关节炎患者态度的研究。

The risk of treatment. A study of rheumatoid arthritis patients' attitudes.

作者信息

Ho M, Lavery B, Pullar T

机构信息

Rheumatic Diseases Unit, Ninewells Hospital, Dundee.

出版信息

Br J Rheumatol. 1998 Apr;37(4):459-60. doi: 10.1093/rheumatology/37.4.459.

DOI:10.1093/rheumatology/37.4.459
PMID:9619900
Abstract

Despite its importance, there is no well-validated method of measuring patients' concept of 'acceptable' risk of medical treatment. Numerical methods give widely varying results depending on the methodology. We have attempted to assess 'acceptable' risk using relative comparisons. We administered a questionnaire to 67 patients with rheumatoid arthritis (RA). In general, patients' estimate of acceptable risk was less than the actual risk of treatment. Some illogical choices were made, showing poor understanding by patients of the concepts of risk and risk:benefit ratio. Patients appeared willing to accept higher levels of risk from procedures than from drug treatment. Willingness to accept risk in exchange for successful treatment of their RA did not correlate with disease severity, age, willingness to take non-medical risks or family responsibilities.

摘要

尽管其很重要,但目前尚无经过充分验证的方法来衡量患者对医疗“可接受”风险的概念。数值方法根据所采用的方法会得出差异很大的结果。我们试图通过相对比较来评估“可接受”风险。我们对67名类风湿性关节炎(RA)患者进行了问卷调查。总体而言,患者对可接受风险的估计低于实际治疗风险。患者做出了一些不合逻辑的选择,表明他们对风险和风险效益比的概念理解不佳。患者似乎愿意接受手术带来的更高风险水平,而不是药物治疗。为成功治疗类风湿性关节炎而接受风险的意愿与疾病严重程度、年龄、承担非医疗风险的意愿或家庭责任无关。

相似文献

1
The risk of treatment. A study of rheumatoid arthritis patients' attitudes.治疗风险。一项关于类风湿性关节炎患者态度的研究。
Br J Rheumatol. 1998 Apr;37(4):459-60. doi: 10.1093/rheumatology/37.4.459.
2
Risk communication in rheumatoid arthritis.类风湿关节炎中的风险沟通
J Rheumatol. 2003 Mar;30(3):443-8.
3
High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.高剂量化疗与造血干细胞移植:类风湿关节炎患者及风湿病学家的治疗偏好研究
J Rheumatol. 2002 Aug;29(8):1653-8.
4
Unwillingness of rheumatoid arthritis patients to risk adverse effects.类风湿性关节炎患者不愿冒不良反应的风险。
Rheumatology (Oxford). 2002 Mar;41(3):253-61. doi: 10.1093/rheumatology/41.3.253.
5
What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.在治疗选择中,类风湿关节炎患者可接受的获益-风险权衡是什么?来自多国选择实验的证据。
RMD Open. 2024 Jan 9;10(1):e003311. doi: 10.1136/rmdopen-2023-003311.
6
Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices.类风湿关节炎患者对改变治疗方案的抵抗:疾病活动度与患者治疗选择之间的不一致。
Arthritis Rheum. 2007 Jul;56(7):2135-42. doi: 10.1002/art.22719.
7
Pilot study assessing the novel use of musculoskeletal ultrasound in patients with rheumatoid arthritis to improve patient attitudes and adherence to medication.一项初步研究,评估肌肉骨骼超声在类风湿性关节炎患者中的新用途,以改善患者态度和药物依从性。
Int J Rheum Dis. 2016 Jul;19(7):658-64. doi: 10.1111/1756-185X.12402. Epub 2014 May 20.
8
Willingness to accept risk in the treatment of rheumatic disease.风湿性疾病治疗中接受风险的意愿。
J Epidemiol Community Health. 1990 Sep;44(3):249-52. doi: 10.1136/jech.44.3.249.
9
Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study.使用风湿病学依从性问卷识别类风湿关节炎患者口服抗风湿药物治疗不依从风险:一项ARCO子研究
Rheumatol Int. 2017 Jul;37(7):1195-1202. doi: 10.1007/s00296-017-3737-y. Epub 2017 May 17.
10
Rheumatoid arthritis patients' knowledge of the disease and its treatments: a descriptive study.类风湿关节炎患者对疾病及其治疗的认知:一项描述性研究。
Musculoskeletal Care. 2009 Mar;7(1):31-44. doi: 10.1002/msc.138.

引用本文的文献

1
Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?类风湿关节炎患者的药物依从性:为何患者不服用我们开的药?
Rheumatol Int. 2016 Nov;36(11):1535-1542. doi: 10.1007/s00296-016-3566-4. Epub 2016 Sep 24.
2
Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound.类风湿关节炎患者的药物依从性:患者教育、健康素养和肌肉骨骼超声的影响
Biomed Res Int. 2015;2015:150658. doi: 10.1155/2015/150658. Epub 2015 Apr 28.
3
Preferences of patients and health professionals for route and frequency of administration of biologic agents in the treatment of rheumatoid arthritis.
类风湿关节炎治疗中患者及医疗专业人员对生物制剂给药途径和频率的偏好。
Patient Prefer Adherence. 2014 Jan 20;8:93-9. doi: 10.2147/PPA.S55156. eCollection 2014.
4
Measuring pain impact versus pain severity using a numeric rating scale.使用数字评分量表测量疼痛的影响与严重程度。
J Gen Intern Med. 2012 May;27(5):555-60. doi: 10.1007/s11606-011-1926-z. Epub 2011 Nov 12.
5
Treating rheumatoid arthritis to target: the patient version of the international recommendations.达标治疗类风湿关节炎:国际建议的患者版。
Ann Rheum Dis. 2011 Jun;70(6):891-5. doi: 10.1136/ard.2010.146662. Epub 2011 Apr 7.
6
Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.肿瘤坏死因子-α拮抗剂在老年类风湿关节炎治疗中的应用:疗效和安全性评价。
Drugs Aging. 2009;26(8):647-64. doi: 10.2165/11316460-000000000-00000.
7
Patient preferences for treatment of rheumatoid arthritis.类风湿关节炎患者的治疗偏好。
Ann Rheum Dis. 2004 Nov;63(11):1372-8. doi: 10.1136/ard.2003.019422. Epub 2004 Mar 5.